Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2)

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1105-1111

  Kawamura, Y ^a   Matsuo, Hirotaka ^a   Chiba, T ^a   Nagamori, S ^b   Nakayama, A ^a   Inoue, H ^a   Utsumi, Y ^a   Oda, T ^a   Nishiyama, J ^c   Kanai, Y ^b   Shinomiya, N ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JSDF Yokosuka Hospital   (Japan)

Author keywords

GLUT1 SLC2A1; GLUT9 SLC2A9; Gout hyperuricemia; Renal hypouricemia; Urate reabsorption transporter

Indexed keywords

ARGININE; GLUTAMATE TRANSPORTER; GLUTAMATE TRANSPORTER 9; UNCLASSIFIED DRUG; URATE; VESICULAR GLUTAMATE TRANSPORTER 1;

ARTICLE; GENE EXPRESSION; GENE LOCATION; GENETIC CONSERVATION; HUMAN; HYPOURICEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MEMBRANE STRUCTURE; MISSENSE MUTATION; OOCYTE; PATHOGENESIS; RENAL HYPOURICEMIA TYPE 1;

AMINO ACIDS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CONSERVED SEQUENCE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MOLECULAR TARGETED THERAPY; MUTANT PROTEINS; MUTATION; OOCYTES; RENAL TUBULAR TRANSPORT, INBORN ERRORS; URIC ACID; URINARY CALCULI;

EID: 84855869644     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.623685     Document Type: Article

References (16)

1. Diamond, H. S.; Paolino, J. S. Evidence for a postsecretory reabsorptive site for uric acid in man. J. Clin. Invest. 1973, 52, 1491-1499.
2. Kikuchi, Y.; Koga, H.; Yasutomo, Y.; Kawabata, Y.; Shimizu, E.; Naruse, M.; Kiyama, S.; Nonoguchi, H.; Tomita, K.; Sasatomi, Y.; Takebayashi, S. Patients with renal hypouricemia with exerciseinduced acute renal failure and chronic renal dysfunction. Clin. Nephrol. 2000, 53, 467-472. (Pubitemid 30390077)
3. Enomoto, A.; Kimura, H.; Chairoungdua, A.; Shigeta, Y.; Jutabha, P.; Cha, S. H.; Hosoyamada, M.; Takeda, M.; Sekine, T.; Igarashi, T.; Matsuo, H.; Kikuchi, Y.; Oda, T.; Ichida, K.; Hosoya, T.; Shimokata, K.; Niwa, T.; Kanai, Y.; Endou, H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417, 447-452. (Pubitemid 34563537)
4. Wakida, N.; Tuyen, D. G.; Adachi, M.; Miyoshi, T.; Nonoguchi, H.; Oka, T.; Ueda, O.; Tazawa, M.; Kurihara, S.; Yoneta, Y.; Shimada, H.; Oda, T.; Kikuchi, Y.; Matsuo, H.; Hosoyamada, M.; Endou, H.; Otagiri, M.; Tomita, K.; Kitamura, K. Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J. Clin. Endocrinol. Metab. 2005, 90, 2169-2174. (Pubitemid 40586257)
5. Ichida, K.; Hosoyamada, M.; Hisatome, I.; Enomoto, A.; Hikita, M.; Endou, H.; Hosoya, T. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 2004, 15, 164-173. (Pubitemid 38020708)
6. Döring, A.; Gieger, C.; Mehta, D.; Gohlke, H.; Prokisch, H.; Coassin, S.; Fischer, G.; Henke, K.; Klopp, N.; Kronenberg, F.; Paulweber, B.; Pfeufer, A.; Rosskopf, D.; Völzke, H.; Illig, T.; Meitinger, T.; Wichmann, H. E.; Meisinger, C. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 2008, 40, 430-436. (Pubitemid 351454014)
7. Vitart, V.; Rudan, I.; Hayward, C.; Gray, N. K.; Floyd, J.; Palmer, C. N.; Knott, S. A.; Kolcic, I.; Polasek, O.; Graessler, J.; Wilson, J. F.; Marinaki, A.; Riches, P. L.; Shu, X.; Janicijevic, B.; Smolej-Narancic, N.; Gorgoni, B.; Morgan, J.; Campbell, S.; Biloglav, Z.; Barac-Lauc, L.; Pericic, M.; Klaric, I. M.; Zgaga, L.; Skaric-Juric, T.; Wild, S. H.; Richardson, W. A.; Hohenstein, P.; Kimber, C. H.; Tenesa, A.; Donnelly, L. A.; Fairbanks, L. D.; Aringer, M.; McKeigue, P. M.; Ralston, S. H.; Morris, A. D.; Rudan, P.; Hastie, N. D.; Campbell, H.; Wright, A. F. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 2008, 40, 437-442. (Pubitemid 351450879)
8. Li, S.; Sanna, S.; Maschio, A.; Busonero, F.; Usala, G.; Mulas, A.; Lai, S.; Dei, M.; Orrù, M.; Albai, G.; Bandinelli, S.; Schlessinger, D.; Lakatta, E.; Scuteri, A.; Najjar, S. S.; Guralnik, J.; Naitza, S.; Crisponi, L.; Cao, A.; Abecasis, G.; Ferrucci, L.; Uda, M.; Chen, W. M.; Nagaraja, R. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007, 3, e194.
9. Matsuo, H.; Kamakura, K.; Saito, M.; Okano, M.; Nagase, T.; Tadano, Y.; Kaida, K.; Hirata, A.; Miyamoto, N.; Masaki, T.; Nakamura, R.; Motoyoshi, K.; Tanaka, H.; Tsuji, S. Familial paroxysmal dystonic choreoathetosis: clinical findings in a large Japanese family and genetic linkage to 2q. Arch Neurol. 1999, 56, 721-726. (Pubitemid 29266473)
10. Anzai, N.; Ichida, K.; Jutabha, P.; Kimura, T.; Babu, E.; Jin, C. J.; Srivastava, S.; Kitamura, K.; Hisatome, I.; Endou, H.; Sakurai, H. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J. Biol. Chem. 2008, 283, 26834-26838.
11. Wu, X. W.; Lee, C. C.; Muzny, D. M.; Caskey, C. T. Urate oxidase: primary structure and evolutionary implications. Proc. Natl. Acad. Sci. USA 1989, 86, 9412-9416. (Pubitemid 20010436)
12. Augustin, R.; Carayannopoulos, M. O.; Dowd, L. O.; Phay, J. E.; Moley, J. F.; Moley, K. H. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J. Biol. Chem. 2004, 279, 16229-16236. (Pubitemid 38509316)
13. Matsuo, H.; Chiba, T.; Nagamori, S.; Nakayama, A.; Domoto, H.; Phetdee, K.; Wiriyasermkul, P.; Kikuchi, Y.; Oda, T.; Nishiyama, J.; Nakamura, T.; Morimoto, Y.; Kamakura, K.; Sakurai, Y.; Nonoyama, S.; Kanai, Y.; Shinomiya, N. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 2008, 83, 744-751.
14. Dinour, D.; Gray, N. K.; Campbell, S.; Shu, X.; Sawyer, L.; Richardson, W.; Rechavi, G.; Amariglio, N.; Ganon, L.; Sela, B. A.; Bahat, H.; Goldman, M.; Weissgarten, J.; Millar, M. R.; Wright, A. F.; Holtzman, E. J. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J. Am. Soc. Nephrol. 2010, 21, 64-72.
15. Pascual, J. M.; Wang, D.; Yang, R.; Shi, L.; Yang, H.; De Vivo, D. C. Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants. J. Biol. Chem. 2008, 283, 16732-16742.
16. Sato, M.; Mueckler, M. A conserved amino acid motif (R-X-G-R-R) in the Glut1 glucose transporter is an important determinant of membrane topology. J. Biol. Chem. 1999, 274, 24721-24725.